Expleo Solutions Limited (NSE: EXPLEOSOL), ISIN INE201K01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EXPLEOSOL last traded at ₹927.45 (+14.78%), with a 52-week range of ₹644.10 to ₹1299.95 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 71.05%, FIIs 0.13%, DIIs 0.12%, mutual funds 0.00%.
EquiSense Score (ECS): 72/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.